ArriVent BioPharma, Inc. AVBP
13.01 USD -0.06 (-0.46%)
Regular-session close
13.01 0.00 0.00%
After hours · Nov 13, 4:26 PM ET
12.59 Day range 13.24
12.23 52-week range 34.74
- YTD
- -35.34%
- 1 year
- -33.89%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -177.53M | -94.31M | -74.59M | -36.91M | |
| -166.31M | -80.49M | -69.33M | -36.91M | |
| -4.32 | -2.56 | -32.38 | -28.90 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 45.54M | 74.29M | 150.39M | 163.37M | |
| 333.17M | 274.94M | 163.10M | 182.83M | |
| 25.95M | 17.29M | 11.80M | 8.37M | |
| 14.00K | 176.00K | 317.00K | 139.00K | |
| 307.22M | 257.65M | -153.19M | -85.11M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -160.59M | -70.21M | -55.84M | -43.63M | |
| -71.23M | -192.47M | 0 | 0 | |
| 203.06M | 186.58M | 42.86M | 169.72M | |
| -28.75M | -76.10M | -12.98M | 126.09M |